In this study, we identified F-LT1-3, a peptide derived from the Slit2-LamG domain, which exhibits dual roles in inhibiting the proliferation and invasion of lung cancer cells but not in inhibiting the proliferation of normal cell types. Here, SLIT2 is linked to lung cancer.